WE TAKE YOU
A CHANGE IS COMING. ARE YOU READY?
WHO ARE WE
Ourobionics deep technology enables human tissues & organs to become cyborganic to transform regenerative medicine. Our high throughput complex tissue structures embedded with biosensors allow for a high biomimicry level providing real-time output on the physiological and biomechanical processes.
We envision long-term our cyborganic human tissues to play a pivotal role in the treatment of diseases and enhance longevity.
Our mission is to speed up drug discovery, lower the costs of pharma R&D, & replace animal testing.
Ourobionics team brings business and industry experts together with academic experts. Together we have 50+ years of combined experience in research and corporate environment.
Chief Executive Officer
John is an entrepreneur with 20+ years of international business experience. He has held sales and marketing leading positions with several companies before starting his own consultancy company providing business management and business development services to companies in life sciences, IVD and medical devices.
PROF. SUWAN N. JAYASINGHE
Chief Scientific Officer
Suwan leads the BioPhysics Group at University College London. He has published over 150 publications in the field of tissue engineering and regenerative medicine including documented evidence of how his inventions of 3D bioelectrospraying, electrohydrodynamic jetting, and cell electrospinning overcome all of the limitations associated with extrusion bioprinting.
PROF. ALIREZA D. PIROUZ
Chief Technology Officer
Alireza is a professor at DTU Nanotech, Denmark, with over 90 publications engineering, nanomaterials, regenerative medicine and cyborganic technology. He is developing printable, moldable and electrically conductive materials with self-healing capacities for applications within the emerging fields of flexible electronics, cyborganics, and soft robotics.
PROF. ALVARO MATA
Chief Innovation Officer
Alvaro is the Chair in Biomedical Engineering & Biomaterials, University of Nottingham specializing in in vitro biomimetic environments. He utilizes molecular printing within 3D environments to create dynamic and directed self-assembling systems, and molecularly-designed bioactive implants for applications in drug screening, regenerative medicine etc. He is the co-inventor of multiple biomaterial patents, including the first 4D self-assembly printable bioink.
DR. STEPHEN G. GRAY
Stephen is a serial entrepreneur with over 10 years of experience in 3D bioenginering with the strong skillset in data science, business intelligence, and non-dilutive funding assistance. He is a co-inventor of merging electrospinning, electrohydrodynamic jetting of cells and bioelectrospraying with extrusion 3D bioprinting.
Chief Marketing Officer
Doris is currently pursuing a PhD degree in structural biology at the University of Gothenburg, Sweden, and assisting several early-stage startup ventures. By integrating hands-on skills in graphic design, web design and marketing with her broad scientific background, she has successfully established the Ourobionics brand and co-ordinated communication across our outreach platforms.
Meet us in Pisa, Italy
on Sep 25-28
at BIOFABRICATION 2022
Prof Alvaro Mata
Univeristy of Nottingham, UK
Don't miss out on Ourobionics'
co-founder and Chief Innovation Officer
Prof Alvaro Mara giving the plenary talk on bioinspired approaches to design and fabricate innovative materials, and devices for tissue engineering and regenerative medicine. Alvaro will be taking the floor on Monday Sep 26th in Verdi Theatre.
Dr Stephen G. Gray
On Wednesday Sep 28th our
co-founder and Chief Operational Officer Stephen G.Gray is giving a talk "A journey on building multiple start-ups in regenerative medicine, empowering academic entrepreneurship, & the emergence of 4D bioprinting & cyborganics to transform numerous industries”.
Ourobionics announces its co-founding team and a strategic alliance with Invitech to multiplex advanced tissue engineering technologies with 3D bioprinting and cyborganics
We are officially presenting our co-founding team, formed by professionals with over 50 years of combined expertise in tissue engineering, 3D biofabrication, regenerative medicine, and cyborganics/human-machine interfaces. We have also entered a partnership with Invictech that sets the grounds for developing a multiplex 3D biofabrication platform.
Ourobionics becomes a distribution partner for Humabiologics products in Europe
We are happy to announce Ourobionics entered into a non-exclusive agreement with Humabiologics, a US biotech company specializing in the development and commercialization of human biomaterials for regenerative medicine research applications. The partnership agreement allows Humabiologics to respond to the growing demand and serve a broader life sciences customer base of industry partners and academic institutions in the European market.